Fenofibrate Patent Expiration

Fenofibrate is Used for managing high levels of cholesterol and triglycerides in the blood. It was first introduced by Abbvie Inc in its drug Lipidil on Dec 31, 1993. Other drugs containing Fenofibrate are Fenoglide, Triglide, Tricor, Lipofen, Tricor (Micronized), Antara (Micronized). 38 different companies have introduced drugs containing Fenofibrate.


Fenofibrate Patents

Given below is the list of patents protecting Fenofibrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Antara (micronized) US9314447 Reduced dose pharmaceutical compositions of fenofibrate May 31, 2033 Lupin
Antara (micronized) US8026281 Treating metabolic syndrome with fenofibrate Apr 22, 2025

(Expired)

Lupin
Fenoglide US7658944 Solid dosage form comprising a fibrate Dec 09, 2024

(Expired)

Salix
Fenoglide US8124125 Solid dosage form comprising a fibrate Oct 01, 2024

(Expired)

Salix
Fenoglide US8481078 Solid dosage form comprising a fibrate Oct 01, 2024

(Expired)

Salix
Fenoglide US9173847 Tablet comprising a fibrate Oct 01, 2024

(Expired)

Salix
Tricor US7276249 Nanoparticulate fibrate formulations Feb 21, 2023

(Expired)

Abbvie
Tricor US7320802 Methods of treatment using nanoparticulate fenofibrate compositions Feb 21, 2023

(Expired)

Abbvie
Triglide US6696084 Spray drying process and compositions of fenofibrate Sep 11, 2021

(Expired)

Skyepharma Ag
Tricor US6375986 Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate Sep 21, 2020

(Expired)

Abbvie
Antara (micronized) US7101574 Pharmaceutical composition containing fenofibrate and the preparation method Aug 20, 2020

(Expired)

Lupin
Antara (micronized) US7863331 Pharmaceutical composition containing fenofibrate and method for the preparation thereof Aug 08, 2020

(Expired)

Lupin
Tricor US6074670 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it Jan 09, 2018

(Expired)

Abbvie
Tricor US6277405 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it Jan 09, 2018

(Expired)

Abbvie
Tricor US6589552 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it Jan 09, 2018

(Expired)

Abbvie
Tricor US6652881 Fenofibrate pharmaceutical composition having high bioavailability Jan 09, 2018

(Expired)

Abbvie
Tricor US7037529 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it Jan 09, 2018

(Expired)

Abbvie
Tricor US7041319 Fenofibrate pharmaceutical composition having high bioavailabilty Jan 09, 2018

(Expired)

Abbvie
Lipofen US5545628 Pharmaceutical composition containing fenofibrate Jan 10, 2015

(Expired)

Cipher Pharms Inc



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fenofibrate's patents.

Given below is the list recent legal activities going on the following patents of Fenofibrate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 22 Jul, 2019 US7320802(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 02 Apr, 2019 US7276249(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 16 Oct, 2017 US7037529(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 16 Oct, 2017 US7041319(Litigated)
File Marked Found 18 Apr, 2016 US6652881
File Marked Found 18 Apr, 2016 US6589552(Litigated)
File Marked Found 07 Apr, 2016 US6589552(Litigated)
File Marked Found 07 Apr, 2016 US6652881
File Marked Found 05 Apr, 2016 US6589552(Litigated)
File Marked Found 05 Apr, 2016 US6652881


Fenofibrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fenofibrate Generic API Manufacturers

Several generic applications have been filed for Fenofibrate. The first generic version for Fenofibrate was by Rhodes Pharmaceuticals Lp and was approved on Apr 9, 2002. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Nov 13, 2024.

Given below is the list of companies who have filed for Fenofibrate generic, along with the locations of their manufacturing plants worldwide.